Terms: = Lung cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Diagnosis
161 results:
1. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
Saberzadeh-Ardestani B; Khosravi AA; Mansour-Ghanaei F; Vahedi H; Baniasadi N; Seyyedmajidi M; Parhizkar B; Hormati A; Naghshbandi SJ; Matin S; Hassan Zadeh AA; Taghvaei T; Bahrami M; Rafeey M; Ahadi M; Vossoughinia H; Muosavi H; Gheibi S; Hosseini-Hemmatabadi RS; Yazdanbod A; Matinkhah S; Sheikh Esmaeili F; Fakheri H; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Farahmand F; Najafi M; Alimadadi H; Malekzadeh M; Anushiravani A; Kasaeian A; Alatab S; Sadeghi A; Radmard AR; Kolahdoozan S; Rajabi Z; Sima AR
Arch Iran Med; 2024 Apr; 27(4):183-190. PubMed ID: 38685844
[TBL] [Abstract] [Full Text] [Related]
2. An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury.
Riveiro-Barciela M; Barreira-Díaz A; Salcedo MT; Callejo-Pérez A; Muñoz-Couselo E; Iranzo P; Ortiz-Velez C; Cedrés S; Díaz-Mejía N; Ruiz-Cobo JC; Morales R; Aguilar-Company J; Zamora E; Oliveira M; Sanz-Martínez MT; Viladomiu L; Martínez-Gallo M; Felip E; Buti M
Aliment Pharmacol Ther; 2024 Apr; 59(7):865-876. PubMed ID: 38327102
[TBL] [Abstract] [Full Text] [Related]
3. lung cancer Cell-Derived Exosome Detection Using Electrochemical Approach towards Early cancer Screening.
Irani K; Siampour H; Allahverdi A; Moshaii A; Naderi-Manesh H
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139054
[TBL] [Abstract] [Full Text] [Related]
4. Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Bafaloukos D; Kouzis P; Gouveris P; Boukovinas I; Kalbakis K; Baka S; Kyriakakis G; Moschou D; Molfeta A; Demiri S; Mavroudis D; Spanoudi F; Dimitriadis I; Gogas H
Melanoma Res; 2024 Apr; 34(2):152-165. PubMed ID: 38092014
[TBL] [Abstract] [Full Text] [Related]
5. [Exploration of the Perturbation of PKIG in lung Squamous Cell Carcinoma and the Role in Tumor Microenvironment Based on Bioinformatics Method].
Liu Q; Li H; Li B; Ren M; Li Z; Chen Y; Zheng Z; Meng Y; Feng H
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):523-537. PubMed ID: 37653016
[TBL] [Abstract] [Full Text] [Related]
6. Tocilizumab in grade 4 hepatitis secondary to immune checkpoint inhibitor: a case report and review of the literature.
Ali SB; Vembar P; Sukumaran S; Gunawardane D; Hughes T; Smith A
Immunotherapy; 2023 Oct; 15(14):1125-1132. PubMed ID: 37401340
[TBL] [Abstract] [Full Text] [Related]
7. An immune checkpoint-based signature predicts prognosis and chemotherapy response for patients with small cell lung cancer.
Wang L; Wu P; Shen Z; Yu Q; Zhang Y; Ye F; Chen K; Zhao J
Int Immunopharmacol; 2023 Apr; 117():109827. PubMed ID: 36989973
[TBL] [Abstract] [Full Text] [Related]
8. Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario.
Bertaglia V; Morelli AM; Solinas C; Aiello MM; Manunta S; Denaro N; Tampellini M; Scartozzi M; Novello S
Crit Rev Oncol Hematol; 2023 Apr; 184():103954. PubMed ID: 36878396
[TBL] [Abstract] [Full Text] [Related]
9. Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.
Müller-Jensen L; Knauss S; Ginesta Roque L; Schinke C; Maierhof SK; Bartels F; Finke C; Rentzsch K; Ulrich C; Mohr R; Stenzel W; Endres M; Boehmerle W; Huehnchen P
Front Immunol; 2023; 14():1108116. PubMed ID: 36845122
[TBL] [Abstract] [Full Text] [Related]
10. Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell lung cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report.
Dias E Silva D; Borba GB; Beal JR; Botrus G; Osawa A; Araújo SEA; Moura F; Guendelmann RAK; Uson Junior PLS
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835617
[TBL] [Abstract] [Full Text] [Related]
11. Application of Immune Checkpoint Inhibitors in Gynecological cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
Lee SM; Lee S; Cho HW; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674491
[TBL] [Abstract] [Full Text] [Related]
12. Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma.
Guo Q; Wu CY; Jiang N; Tong S; Wan JH; Xiao XY; Mei PY; Liu HS; Wang SH
Front Immunol; 2022; 13():986447. PubMed ID: 36544782
[TBL] [Abstract] [Full Text] [Related]
13. A case report of anterior mediastinal signet ring cell carcinoma.
Liu S; Zhao A; Mao M
Medicine (Baltimore); 2022 Dec; 101(48):e32202. PubMed ID: 36482538
[TBL] [Abstract] [Full Text] [Related]
14. Old and New Blood Markers in Human Colorectal cancer.
Wautier JL; Wautier MP
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361758
[TBL] [Abstract] [Full Text] [Related]
15. Morphological and immunohistochemical diagnostic of extragastrointestinal stromal tumors - a 51 case series analysis.
Moldovan VT; Pătraşcu OM; Ali L; Costache M; Sajin M
Rom J Morphol Embryol; 2021; 62(4):1011-1016. PubMed ID: 35673820
[TBL] [Abstract] [Full Text] [Related]
16. Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors.
Chennamadhavuni A; Abushahin L; Jin N; Presley CJ; Manne A
Front Immunol; 2022; 13():779691. PubMed ID: 35558065
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Beacon for Detection miRNA-21 as a Biomarker of lung cancer.
Alexandre D; Teixeira B; Rico A; Valente S; Craveiro A; Baptista PV; Cruz C
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328750
[TBL] [Abstract] [Full Text] [Related]
18. CD8
Zhang M; Ma J; Guo Q; Ding S; Wang Y; Pu H
Front Immunol; 2022; 13():806877. PubMed ID: 35273597
[TBL] [Abstract] [Full Text] [Related]
19. Common Variable Immunodeficiency-Associated cancers: The Role of Clinical Phenotypes, Immunological and Genetic Factors.
Bruns L; Panagiota V; von Hardenberg S; Schmidt G; Adriawan IR; Sogka E; Hirsch S; Ahrenstorf G; Witte T; Schmidt RE; Atschekzei F; Sogkas G
Front Immunol; 2022; 13():742530. PubMed ID: 35250968
[TBL] [Abstract] [Full Text] [Related]
20. The additional value of lung cancer screening program in identifying unrecognized diseases.
Finamore P; Tanese L; Longo F; De Stefano D; Pedone C; Angelici L; Agabiti N; Cascini S; Davoli M; Zobel BB; Incalzi RA; Crucitti P
BMC Pulm Med; 2022 Jan; 22(1):48. PubMed ID: 35101007
[TBL] [Abstract] [Full Text] [Related]
[Next]
